DRUG ACCESS REQUESTS FOR INNOVATIVE THERAPIES FOR PEDIATRIC ONCOLOGY PATIENTS IN CANADA

被引：0
|
作者：
Judd, Sandra [1 ]
Revon-Riviere, Gabriel [2 ]
Deyell, Rebecca J. [3 ]
Vanan, Magimairajan Issai [4 ]
Pecheux, Lucie [5 ]
Zorzi, Alexandra P. [6 ]
Santiago, Raoul [7 ]
Tran, Thai Hoa [8 ]
Grover, Stephanie A. [9 ]
Cohen-Gogo, Sarah [2 ]
Morgenstern, Daniel [2 ]
机构：
[1] Hosp Sick Children, Dept Pharm, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Temerty Fac Med, Peditat Hematol Oncol, Toronto, ON, Canada
[3] Univ British Columbia, British Columbia Childrens Hosp, Pediat, Div Pediat Hematol Oncol Bmt, Vancouver, BC, Canada
[4] Univ Manitoba, Canc Care Manitoba Pediat & Child Hlth, Winnipeg, MB, Canada
[5] Univ Alberta, Stollery Childrens Hosp, Pediat Hematol Oncol, Edmonton, AB, Canada
[6] Childrens Hosp, London Hlth Sci Ctr, Pediat, London, ON, Canada
[7] Laval Univ, CHU Quebec, Pediat, Laval, PQ, Canada
[8] CHU St Justine, Pediat, Montreal, PQ, Canada
[9] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP365
引用
收藏
页码：S317 / S318
页数：2
相关论文
共 50 条
  • [1] MAPPING THE TERRITORY OF INNOVATIVE DRUG THERAPY ACCESS FOR PEDIATRIC ONCOLOGY PATIENTS IN CANADA
    Judd, Sandra
    Revon-Riviere, Gabriel
    Denburg, Avram
    Deyell, Rebecca J.
    Grover, Stephanie A.
    Pecheux, Lucie
    Santiago, Raoul
    Tran, Thai Hoa
    Vanan, Magimairajan Issai
    Zorzi, Alexandra P.
    Cohen-Gogo, Sarah
    Morgenstern, Daniel
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S447 - S447
  • [2] Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada
    Judd, Sandra
    Revon-Riviere, Gabriel
    Grover, Stephanie A.
    Deyell, Rebecca J.
    Vanan, Magimairajan Issai
    Lewis, Victor A.
    Pecheux, Lucie
    Zorzi, Alexandra P.
    Goudie, Catherine
    Santiago, Raoul
    Tran, Thai Hoa
    Abbott, Lesleigh S.
    Brossard, Josee
    Moorehead, Paul
    Alvi, Saima
    Portwine, Carol
    Denburg, Avram
    Whitlock, James A.
    Cohen-Gogo, Sarah
    Morgenstern, Daniel A.
    CANCER MEDICINE, 2024, 13 (03):
  • [3] A review of the experience with pediatric written requests issued for oncology drug products
    Akalu, Alemayehu Y.
    Meng, Xi
    Reaman, Gregory H.
    Ma, Lian
    Yuan, Weishi
    Ye, Jingjing
    PEDIATRIC BLOOD & CANCER, 2021, 68 (02)
  • [4] UNEQUAL ACCESS OF INNOVATIVE DRUG PRODUCTS ACROSS CANADA
    Feener, S.
    Barbeau, M.
    VALUE IN HEALTH, 2023, 26 (12) : S330 - S330
  • [5] VENOUS ACCESS IN PEDIATRIC ONCOLOGY PATIENTS
    ALBANESE, CT
    WIENER, ES
    SEMINARS IN SURGICAL ONCOLOGY, 1993, 9 (06): : 467 - 477
  • [6] Comment on: A review of the experience with pediatric written requests issued for oncology drug products
    Rose, Klaus
    Grant-Kels, Jane M.
    Ettienne, Earl B.
    Tanjinatus, Oishi
    Striano, Pasquale
    Neubauer, David
    PEDIATRIC BLOOD & CANCER, 2021, 68 (08)
  • [7] INNOVATIVE THERAPIES IN HEMATOLOGY AND ONCOLOGY
    HANSON, DS
    BROOKS, BJ
    MEDICAL CLINICS OF NORTH AMERICA, 1992, 76 (05) : 1169 - 1184
  • [8] Molecular oncology: what is needed to speed access to innovative therapies in clinical research?
    Gourari, Karim
    Awada, Ahmad
    Kotecki, Nuria
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (05) : 575 - 578
  • [9] IMPACT OF CLINICAL PHARMACIST IN OPTIMIZATION OF DRUG THERAPIES FOR EFFECTIVE OUTCOMES IN HOSPITALIZED PEDIATRIC ONCOLOGY PATIENTS
    Shakil, Summyya
    Hanif, Ayesha
    Ali, Arif
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S468 - S469
  • [10] Drug-drug interactions in pediatric oncology patients
    Balk, T. E.
    van der Sijs, I. H.
    van Gelder, T.
    Janssen, J. J. B.
    van der Sluis, I. M.
    van Leeuwen, R. W. F.
    Engels, F. K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (07)
12345